The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

Item
http://www.wikidata.org/entity/Q34748167
A Novel Prioritization Method in Identifying Recurrent Venous Thromboembolism-Related GenesIdentification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion.Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusionTyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?Oncocardiology-Past, Present, and Future: A Review.Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia.Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab.Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case report.Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model.Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylationMechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis
P2860

The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

Item
http://www.wikidata.org/entity/Q34748167
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@ast
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@en
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@nl
type
label
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@ast
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@en
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@nl
prefLabel
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@ast
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@en
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
The BCR-ABL inhibitor ponatini ...... gregate formation under shear.
@en
P2093
P2860
P304
P31
P356
10.1016/J.THROMRES.2014.11.009
P433
P478
P50
P577
P698
P932